BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugarbaker PH, Van der Speeten K, Stuart OA. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol 2010; 2(1): 19-30 [PMID: 21160813 DOI: 10.4251/wjgo.v2.i1.19] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Saraswat N, Gupta A, Kaur M, Mahajan S. Anaesthesia concerns for Peritonectomy with Hyperthermic Intraoperative Peritoneal Chemotherapy. Saudi J Anaesth 2019;13:169-71. [PMID: 31007679 DOI: 10.4103/sja.SJA_12_17] [Reference Citation Analysis]
2 Braam HJ, Schellens JH, Boot H, van Sandick JW, Knibbe CA, Boerma D, van Ramshorst B. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer. Crit Rev Oncol Hematol. 2015;95:282-296. [PMID: 25921419 DOI: 10.1016/j.critrevonc.2015.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
3 Liesenfeld LF, Hillebrecht HC, Klose J, Schmidt T, Schneider M. Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model. J Surg Res 2020;253:262-71. [PMID: 32388389 DOI: 10.1016/j.jss.2020.03.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Macrì A. New approach to peritoneal surface malignancies. World J Gastrointest Oncol 2010; 2(1): 9-11 [PMID: 21160811 DOI: 10.4251/wjgo.v2.i1.9] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Kireeva GS, Gafton GI, Guseynov KD, Senchik KY, Belyaeva OA, Bespalov VG, Panchenko AV, Maydin MA, Belyaev AM. HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes. Surg Oncol 2018;27:251-8. [PMID: 29937179 DOI: 10.1016/j.suronc.2018.05.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K. Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial. Ann Surg Oncol 2017;24:1916-22. [PMID: 28224367 DOI: 10.1245/s10434-017-5814-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 van der Kaaij RT, Wassenaar ECE, Koemans WJ, Sikorska K, Grootscholten C, Los M, Huitema A, Schellens JHM, Veenhof AAFA, Hartemink KJ, Aalbers AGJ, van Ramshorst B, Boerma D, Boot H, van Sandick JW. Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results. Br J Surg 2020;107:1520-8. [PMID: 32277764 DOI: 10.1002/bjs.11588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
8 Lee SJ, Jeon Y, Lee HW, Kang J, Baik SH, Park EJ. Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis. Ann Surg Oncol 2021. [PMID: 34665362 DOI: 10.1245/s10434-021-10924-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mistry P, Mohamed F, Dayal S, Cecil TD, Moran BJ. Cytoreductive surgery with intraperitoneal chemotherapy in the management of peritoneal surface malignancy: a pharmacist's perspective. Eur J Hosp Pharm 2016;23:233-8. [PMID: 31156855 DOI: 10.1136/ejhpharm-2016-000877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Gupta N, Asif S, Gandhi J, Rajpurohit S, Singh S. Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience. Indian J Gastroenterol 2017;36:126-30. [PMID: 28393331 DOI: 10.1007/s12664-017-0747-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
11 Park EJ, Baik SH, Hur H, Min BS, Kang J, Han YD, Cho MS, Lee KY, Kim NK. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea. Medicine (Baltimore) 2017;96:e6632. [PMID: 28538365 DOI: 10.1097/MD.0000000000006632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 2013;257:1065-71. [PMID: 23299520 DOI: 10.1097/SLA.0b013e31827e9289] [Cited by in Crossref: 166] [Cited by in F6Publishing: 49] [Article Influence: 18.4] [Reference Citation Analysis]
13 Behrenbruch C, Hollande F, Thomson B, Michael M, Warrier SK, Lynch C, Heriot A. Treatment of peritoneal carcinomatosis with hyperthermic intraperitoneal chemotherapy in colorectal cancer. ANZ J Surg 2017;87:665-70. [PMID: 28664645 DOI: 10.1111/ans.14077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Leung V, Huo YR, Liauw W, Morris DL. Oxaliplatin versus Mitomycin C for HIPEC in colorectal cancer peritoneal carcinomatosis. Eur J Surg Oncol. 2017;43:144-149. [PMID: 27780675 DOI: 10.1016/j.ejso.2016.09.015] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 6.7] [Reference Citation Analysis]
15 Kitai T. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan. Surg Today 2021;51:1085-98. [PMID: 33185798 DOI: 10.1007/s00595-020-02180-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
16 Macrì A. New approach to peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2:9-11. [PMID: 21160811 DOI: 10.4251/wjgo.v2.i1.world] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Murono K, Kazama S, Yamaguchi H, Kawai K, Ishihara S, Sunami E, Kitayama J, Satoh Y, Kurihara M, Yatomi Y. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer. Surgery. 2015;157:322-330. [PMID: 25311262 DOI: 10.1016/j.surg.2014.09.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
18 Leebmann H, Piso P. Hypertherme intraperitoneale Chemotherapie. Chirurg 2019;90:593-604. [DOI: 10.1007/s00104-019-0982-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ha HI, Lim MC. How do we perform hyperthermic intraperitoneal chemotherapy in ovarian cancer? -a narrative review. Gland Surg 2021;10:1235-43. [PMID: 33842270 DOI: 10.21037/gs-20-425] [Reference Citation Analysis]
20 Liang H. Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis. Transl Gastroenterol Hepatol 2016;1:62. [PMID: 28138628 DOI: 10.21037/tgh.2016.07.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
21 Woeste MR, Philips P, Egger ME, Scoggins CR, McMasters KM, Martin RCG. Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer. J Surg Oncol 2020;121:1298-305. [PMID: 32239529 DOI: 10.1002/jso.25920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Sabino FD, Campos CF, Caetano CE, Trotte MN, Oliveira AV, Marques RG. Effects of TachoSil and 5-fluorouracil on colonic anastomotic healing. J Surg Res. 2014;192:375-382. [PMID: 24976442 DOI: 10.1016/j.jss.2014.05.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]